Akshay Vaishnaw - 09 Aug 2021 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
President, R&D
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Akshay K. Vaishnaw
Issuer symbol
ALNY
Transactions as of
09 Aug 2021
Net transactions value
-$1,484,258
Form type
4
Filing time
11 Aug 2021, 16:10:02 UTC
Previous filing
22 Jun 2021
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $682,542 +10,834 +97% $63.00 22,049 09 Aug 2021 Direct F1
transaction ALNY Common Stock Sale $2,166,800 -10,834 -49% $200.00 11,215 09 Aug 2021 Direct F1
holding ALNY Common Stock 515 09 Aug 2021 by Managed Account F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Performance Stock Option 2013 (right to buy) Options Exercise $0 -10,834 -50% $0.000000 10,832 09 Aug 2021 Common Stock 10,834 $63.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2021.
F2 Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.